Clinical effects of Madopar with pramipexole in the treatment of Parkinson's disease

Asian J Surg. 2024 Aug;47(8):3780-3781. doi: 10.1016/j.asjsur.2024.04.126. Epub 2024 May 22.

Authors

Ting-Ting Wang¹, Cong Liu², Lu Zhang³, Jian-Guo Zhu³

Affiliations

¹ Department of Neurology, Harrison International Peace Hospital, Hengshui, Hebei, 053000, China. Electronic address: [email protected].
² Department of Health Management Center, Harrison International Peace Hospital, Hengshui, Hebei, 053000, China.
³ Department of Neurology, Harrison International Peace Hospital, Hengshui, Hebei, 053000, China.

PMID: 38782691
DOI: 10.1016/j.asjsur.2024.04.126

No abstract available

Publication types

Letter

MeSH terms

Aged
Antiparkinson Agents* / therapeutic use
Benzothiazoles / therapeutic use
Dopamine Agonists / therapeutic use
Drug Therapy, Combination
Female
Humans
Levodopa / administration & dosage
Levodopa / therapeutic use
Male
Middle Aged
Parkinson Disease* / drug therapy
Pramipexole* / therapeutic use
Treatment Outcome

Substances

Pramipexole
Antiparkinson Agents
Levodopa
Dopamine Agonists
Benzothiazoles